John R. Teerlink

1.2k total citations
18 papers, 801 citations indexed

About

John R. Teerlink is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John R. Teerlink has authored 18 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John R. Teerlink's work include Heart Failure Treatment and Management (12 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). John R. Teerlink is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). John R. Teerlink collaborates with scholars based in United States, United Kingdom and Netherlands. John R. Teerlink's co-authors include Barry M. Massie, Milton Packer, James B. Young, Wilson S. Colucci, Chris Garratt, Lloyd D. Fisher, Martine Clozel, Roopal Thakkar, Robert J. Padley and Toni Sarapohja and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

John R. Teerlink

18 papers receiving 770 citations

Peers

John R. Teerlink
Anilkumar Mehra United States
Srdjan D. Nikolic United States
Sally S. Cutler United States
Tom S. Rector United States
Laurence H. Green United States
Peter J. Cowburn United Kingdom
Anilkumar Mehra United States
John R. Teerlink
Citations per year, relative to John R. Teerlink John R. Teerlink (= 1×) peers Anilkumar Mehra

Countries citing papers authored by John R. Teerlink

Since Specialization
Citations

This map shows the geographic impact of John R. Teerlink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Teerlink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Teerlink more than expected).

Fields of papers citing papers by John R. Teerlink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Teerlink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Teerlink. The network helps show where John R. Teerlink may publish in the future.

Co-authorship network of co-authors of John R. Teerlink

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Teerlink. A scholar is included among the top collaborators of John R. Teerlink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Teerlink. John R. Teerlink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pagnesi, Matteo, Jozine M. ter Maaten, Iris E. Beldhuis, et al.. (2024). Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure. JACC Heart Failure. 13(3). 414–429. 4 indexed citations
2.
Packer, Milton, Wilson S. Colucci, Lloyd D. Fisher, et al.. (2013). Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure. JACC Heart Failure. 1(2). 103–111. 285 indexed citations
3.
Metra, Marco, Cathal O’Connor, Beth A. Davison, et al.. (2011). Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. European Heart Journal. 32(12). 1519–1534. 74 indexed citations
4.
Teerlink, John R., Roopal Thakkar, Jeffrey E. Salon, Bidan Huang, & Robert J. Padley. (2007). Patient Self-Assessments of Heart Failure Status Using Either Categorical or Continuous Scales Were Highly Correlated in REVIVE I and II. Journal of Cardiac Failure. 13(6). S137–S137. 1 indexed citations
6.
Bart, Bradley A., John R. Teerlink, Maria Rosa Costanzo, Mitchell Saltzberg, & Paul A. Sobotka. (2006). Changes in Serum Creatinine during Treatment of Heart Failure and Volume Overload with Ultrafiltration or Intravenous Diuretics. Journal of Cardiac Failure. 12(6). S114–S114. 1 indexed citations
7.
Teerlink, John R.. (2005). Overview of Randomized Clinical Trials in Acute Heart Failure Syndromes. The American Journal of Cardiology. 96(6). 59–67. 33 indexed citations
8.
Garratt, Chris, Milton Packer, Wilson S. Colucci, et al.. (2004). Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study. Critical Care. 8(Suppl 1). P89–P89. 6 indexed citations
9.
O’Connor, Christopher M., Wendy A. Gattis, John R. Teerlink, Kirkwood F. Adams, & Mihai Gheorghiade. (2003). Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure. American Heart Journal. 145(2). S47–S50. 3 indexed citations
10.
Packer, Milton, Wilson S. Colucci, Lloyd D. Fisher, et al.. (2003). Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study. Journal of Cardiac Failure. 9(5). S61–S61. 35 indexed citations
11.
Schafhalter-Zoppoth, Ingeborg, Mary O. Gray, & John R. Teerlink. (2002). Endothelin antagonism with bosentan, a dual receptor blocker, normalizes dysregulated transforming growth factor beta signaling pathways in rats with chronic heart failure. Journal of the American College of Cardiology. 39. 168–168. 2 indexed citations
12.
Schafhalter-Zoppoth, Ingeborg & John R. Teerlink. (2002). Endothelin antagonism with bosentan improves myocardial mechanics and ventricular remodeling in rats with chronic heart failure. Journal of the American College of Cardiology. 39. 171–171. 1 indexed citations
13.
Teerlink, John R.. (2002). Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): Approaching the asymptote of efficacy?. Journal of Cardiac Failure. 8(3). 124–127. 43 indexed citations
14.
Teerlink, John R., Muhammad Jalaluddin, Susan Anderson, et al.. (2000). Ambulatory Ventricular Arrhythmias in Patients With Heart Failure Do Not Specifically Predict an Increased Risk of Sudden Death. Circulation. 101(1). 40–46. 145 indexed citations
15.
Teerlink, John R. & Barry M. Massie. (1999). The interaction of ACE inhibitors and aspirin in heart failure: Torn between two lovers. American Heart Journal. 138(2). 193–197. 25 indexed citations
16.
Teerlink, John R.. (1996). Neurohumoral Mechanisms in Heart Failure: A Central Role for the Renin-Angiotensin System. Journal of Cardiovascular Pharmacology. 27. 1–8. 22 indexed citations
17.
Teerlink, John R., et al.. (1995). Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. American Journal of Physiology-Heart and Circulatory Physiology. 268(1). H432–H440. 48 indexed citations
18.
Teerlink, John R., Martine Clozel, Walter Fischli, & Jean‐Paul Clozel. (1993). Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. Journal of the American College of Cardiology. 22(2). 615–620. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026